Baoyou Fan
Overview
Explore the profile of Baoyou Fan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
564
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Wang H, Li Y, Wang C, Feng H, Pang Y, et al.
Bioact Mater
. 2025 Jan;
45:534-550.
PMID: 39759534
Spinal cord injury triggers leukocyte mobilization from the peripheral circulation to the injury site, exacerbating spinal cord damage. Simultaneously, bone marrow hematopoietic stem cells (HSCs) and splenic leukocytes rapidly mobilize...
2.
Fan B, Liu D, Qin J, Shi Z, Hu Z, Gao X, et al.
Free Radic Biol Med
. 2024 Dec;
227():129-142.
PMID: 39626861
Ferroptosis has been demonstrated to be involved in the progression of spinal cord injury (SCI). Ferroptosis suppressor protein 1 (FSP1) can inhibit ferroptosis in parallel with Glutathione peroxidase 4 (GPX4)....
3.
Shi Z, Fang T, Fan B, Ma J, Wang J, Feng S
Aging (Albany NY)
. 2024 Jun;
16(11):9990-10003.
PMID: 38862258
The intermediate phase of spinal cord injury (SCI) serves as an important target site for therapeutic mediation of SCI. However, there is a lack of insight into the mechanism of...
4.
Li W, Zhao X, Zhang R, Liu X, Qi Z, Zhang Y, et al.
Neural Regen Res
. 2023 Jun;
18(11):2474-2481.
PMID: 37282479
Maintaining the integrity of the blood-spinal cord barrier is critical for the recovery of spinal cord injury. Ferroptosis contributes to the pathogenesis of spinal cord injury. We hypothesized that ferroptosis...
5.
Ran N, Li W, Zhang R, Lin C, Zhang J, Wei Z, et al.
Bioact Mater
. 2023 Apr;
25:766-782.
PMID: 37056263
Spinal cord injury (SCI) causes motor, sensory and automatic impairment due to rarely axon regeneration. Developing effective treatment for SCI in the clinic is extremely challenging because of the restrictive...
6.
Gu G, Zhu B, Ren J, Song X, Fan B, Ding H, et al.
Cell Biosci
. 2023 Feb;
13(1):23.
PMID: 36739421
Background: Inflammatory response is an essential part of secondary injury after spinal cord injury (SCI). During this period, the injury may be exacerbated through the release of a large number...
7.
Liu D, Fan B, Li J, Sun T, Ma J, Zhou X, et al.
Front Cell Neurosci
. 2022 Oct;
16:989637.
PMID: 36212687
N6-methyladenosine (m6A), an essential post-transcriptional modification in eukaryotes, is closely related to the development of pathological processes in neurological diseases. Notably, spinal cord injury (SCI) is a serious traumatic disease...
8.
Pang Y, Liu X, Wang X, Shi X, Ma L, Zhang Y, et al.
Front Cell Dev Biol
. 2022 Jul;
10:849854.
PMID: 35903552
The FDA-approved drug edaravone has a neuroprotective effect on spinal cord injury (SCI) and many other central nervous system diseases. However, its molecular mechanism remains unclear. Since edaravone is a...
9.
Zhao C, Zhou T, Zhao X, Pang Y, Li W, Fan B, et al.
J Neuroinflammation
. 2022 Jul;
19(1):189.
PMID: 35842640
Background: Nafamostat mesylate (nafamostat, NM) is an FDA-approved serine protease inhibitor that exerts anti-neuroinflammation and neuroprotective effects following rat spinal cord injury (SCI). However, clinical translation of nafamostat has been...
10.
Fan B, Wei Z, Feng S
Bone Res
. 2022 Apr;
10(1):35.
PMID: 35396505
Spinal cord injury (SCI) leads to loss of motor and sensory function below the injury level and imposes a considerable burden on patients, families, and society. Repair of the injured...